Investing Profile

Frank Kalkbrenner

InvestorVC
Director, Investment Manager at Hotmail
Photo of Frank Kalkbrenner, Hotmail

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
5844 CONNECTIONS
Hotmail Network
5844 CONNECTIONS
Hotmail Network
5844 CONNECTIONS
various Network
445 CONNECTIONS
various Network
445 CONNECTIONS
cb
$3.3M - $17.0M
$8.5M
9
CompanyStageDateRound SizeTotal Raised
Rinri Therapeutics
Series UnknownApr 2021$12M
$14M
Co-investors: Claire Brown (Oxford Science Enterprises)
T3 Pharmaceuticals
Series CJul 2020$27M
Series BSep 2019$12M
$39M
Amal Therapeutics
Series BNov 2018$33M
Series BSep 2017$10M
Series AMar 2016$3M
$46M
Co-investors: Frank Hensel (HTGF | High-Tech Gründerfonds)
Hookipa Pharma
Series CDec 2017$60M
Series BDec 2016$11M
Series BNov 2013$27M
$110M
Co-investors: Graziano Seghezzi (Sofinnova Partners)
Post-doctoral fellow variousPresent
VicePresident R&D Licensing and Information Management variousPresent
Director, Investment Manager variousPresent
Post-doctoral fellow HotmailPresent
Research Group Leader, Institute of Pharmacology Freie Universität BerlinPresent
Senior Scientist, Dermatology Research BayerPresent
Senior Scientist, Pulmonary Research Boehringer IngelheimPresent
Director, Pulmonary Research Boehringer IngelheimPresent
VicePresident R&D Licensing and Information Management HotmailPresent
Director, Investment Manager HotmailPresent
Freie Universität Berlin Dr. med. Medizin
Sign in with Google →
Sign in with Google →